Drug Type Monoclonal antibody |
Synonyms anti-Chi3l1 humanized mAb(Ocean Biomedical), anti-Chi3l1 monospecific monoclonal antibody(Brown University), anti-chitinase-3-like protein 1 monoclonal antibody(Ocean Biomedical) + [1] |
Target |
Action inhibitors |
Mechanism CHI3L1 inhibitors(chitinase 3 like 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 1 | United States | 02 Sep 2022 |